Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01780441 · ClinicalTrials.gov registry record
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 166
- Enrollment target
NCT01780441 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 166 participants.
The verdict
NCT01780441 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
The investigators are enrolling 3-12 month old infants with a diagnosis of tuberous sclerosis complex (TSC) for a new study on early markers of autism. The study is looking for early signs for autism in a population (TSC) where autism is common. The goal of this project is to use behavioral testing, MRI and EEG techniques to identify children at risk for developing autism starting at 3 months of age and continuing until 36 months of age. Throughout the study, the investigators will recommend Early Intervention services for any child who shows early signs of autism.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2013-01 |
| Est. Completion | 2020-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01780441
The ClinicalTrials.gov registry entry for NCT01780441 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01780441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01780441 about?
NCT01780441 is a clinical study titled "Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)". The investigators are enrolling 3-12 month old infants with a diagnosis of tuberous sclerosis complex (TSC) for a new study on early markers of autism. The study is looking for early signs for autism in a population (TSC) where autism is common. The goal of this project is to use behavioral testing,...
What is the current status of trial NCT01780441?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2013-01. Estimated completion is 2020-12.
Who is sponsoring clinical trial NCT01780441?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.